Join
Live feed
·
INSIDERFilingvia Quantisnow
Acceleron Pharma Inc. logo

SEC Form 4: Kango Sujay closing all direct ownership in the company (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
XLRN· Acceleron Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XLRN (Acceleron Pharma Inc.) and more on Quantisnow.